Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma

Lei Wang; Hui Dong; Shujuan Ni; Dan Huang; Cong Tan; Bin Chang; Weiqi Sheng

doi:10.18632/oncotarget.11949

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma

Lei Wang, Hui Dong, Shujuan Ni, Dan Huang, Cong Tan, Bin Chang and Weiqi Sheng _

PDF | HTML | How to cite

Oncotarget. 2016; 7:69749-69759. https://doi.org/10.18632/oncotarget.11949

Metrics: PDF 1737 views | HTML 2820 views | ?

Abstract

Lei Wang1,2,*, Hui Dong3,*, Shujuan Ni1,2, Dan Huang1,2, Cong Tan1,2, Bin Chang1,2, Weiqi Sheng1,2

1Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China

2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China

3Department of Pathology, Shanghai Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, 200438, China

*These authors contributed equally to this work

Correspondence to:

Weiqi Sheng, email: [email protected]

Keywords: intrahepatic cholangiocarcinoma, intrahepatic lymphoepithelioma-like cholangiocarcinoma, clinicopathological characteristics, PD-L1, clinical outcomes

Received: May 10, 2016 Accepted: September 02, 2016 Published: September 10, 2016

ABSTRACT

Intrahepatic lymphoepithelioma-like cholangiocarcinoma (LELCC) is a rare variant of cholangiocarcinoma. Here, we report the largest single series of LELCC cases yet studied (n = 13). We retrospectively analyzed the clinical data of the 13 patients and measured the expression of programmed death-ligand 1 (PD-L1) in tumors using immunohistochemical staining. We also analyzed 15 cases of conventional intrahepatic cholangiocarcinoma (IHCC) for comparison. We found that eight patients with LELCC were infected with Epstein-Barr Virus (EBV), and EBV infection correlated with poor prognosis in LELCC. Four patients among the five (80.0%) without EBV had a history of chronic viral hepatitis B. None of the 15 cases of conventional cholangiocarcinoma were positive for EBV. PD-L1 was expressed in both the tumor cells and tumor-infiltrating immune cells in LELCC patients at higher levels than in IHCC patients (P < 0.05). These observations suggest that EBV infection may promote the development of LELCC, and that PD-L1 may be a potential therapeutic target for treatment of EBV-associated LELCC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11949

Publication Alerts

Research Papers:

Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma

Abstract